Violeta Serra
Vall d'Hebron Institute of Oncology
18 papers found
Refreshing results…
BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors
UploadMiR ‐182‐3p targets TRF2 and impairs tumor growth of triple‐negative breast cancer
Download from onlinelibrary.wiley.comMYC Inhibition Halts Metastatic Breast Cancer Progression by Blocking Growth, Invasion, and Seeding
UploadINK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase Inhibitors
UploadBiomarkers Associating with PARP Inhibitor Benefit in Prostate Cancer in the TOPARP-B Trial
Download from aacrjournals.orgPI3K activation promotes resistance to eribulin in HER2-negative breast cancer
UploadA RAD 51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation
Download from doi.orgTET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence
Download from doi.orgMissing publications? Search for publications with a matching author name.